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Abstract
In this study, we provide a comprehensive molecular profiling of the involvement of T- helper (Th)
genes during dengue virus infection of different cell types. The Th gene profiles of three human cell
types (monocytes, T-cells and hepatocytes) were analyzed simultaneously via array-based RT-PCR
upon infection with dengue virus. Differential regulation of 41 Th genes was identified and of which
20 of those genes may contribute to immuno-pathogenesis of dengue virus infection by regulating
inflammation, thrombocytopenia and vascular permeability. Among the strongly up-regulated genes
were the RANTES, CC-CKR3, IRF4, CLEC2C, IL-6 and TLR6, which are potent inducer of
inflammation and vascular permeability. Profiling genes obtained from this study may serve as
potential biomarkers and the modulation of Th immune responses during dengue virus infection
has important implications in disease outcome.
Findings
Dengue virus (DENV) is a member of the Flavivirus genus
of the Flaviviridae  family of enveloped, positive-strand
RNA viruses. Four distinct serotypes (DENV1-4) of den-
gue viruses are transmitted to humans through the bites of
the mosquito species, Aedes aegypti and  A. albopictus.
DENV causes a spectrum of disease in human, from acute
febrile illness dengue fever (DF) to life-threatening den-
gue hemorrhagic fever/dengue shock syndrome (DHF/
DSS). It has been estimated that about 50–100 million
cases of DF, and about 250,000–500,000 cases of DHF
occur worldwide every year. Furthermore, 2.5 billion of
people are at risk for infection in subtropical and tropical
regions of the world in the absence of effective interven-
tion [1,2]. It is hypothesized that immunological mecha-
nisms play a key role in the pathogenesis of dengue
infection. Although several gene expression profiling
studies of dengue virus-infected cells have been carried
out previously [3-6], little is currently known about the
molecular mechanism of how Th genes and Th-related
genes are activated and implicated in the immuno-patho-
genesis of DENV infection.
In this study, we conducted a novel focused gene set,
array-based platform of transcriptional Real Time (RT)-
PCR analysis of human cell response to DENV infection
during peak virus production and focused on genes which
are related to the three classes of helper T cells. The three
classes of 84 helper T cells (Th1-Th2-Th3) genes were
simultaneously profiled using the RT-PCR array (Table 1).
Comparative profiling of the Th genes was carried out on
three different human cell types (monocytes, T-cells and
hepatocytes). The data generated from the RT-PCR array
profiling will enable us to determine the crucial virus-cell
interactions that take place during DENV infection. The
RT-PCR arrays revealed differential regulation of 41 Th
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Table 1: Complete list of genes tested in the Th genes RT-PCR array.
No. Gene
1 B-cell CLL/lymphoma 3
2 Chemokine (C-C motif) ligand 11
3 Chemokine (C-C motif) ligand 5
4 Chemokine (C-C motif) ligand 7
5 Chemokine (C-C motif) receptor 2
6 Chemokine (C-C motif) receptor 3
7 Chemokine (C-C motif) receptor 4
8 Chemokine (C-C motif) receptor 5
9 CD28 molecule
10 CD4 molecule
11 CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome)
12 CD69 molecule
13 CD80 molecule
14 CD86 molecule
15 CCAAT/enhancer binding protein (C/EBP), beta
16 CREB binding protein (Rubinstein-Taybi syndrome)
17 Colony stimulating factor 2 (granulocyte-macrophage)
18 Cytotoxic T-lymphocyte-associated protein 4
19 Chemokine (C-X-C motif) receptor 3
20 Fas ligand (TNF superfamily, member 6)
21 GATA binding protein 3
22 Growth factor independent 1
23 Glomulin, FKBP associated protein
24 G protein-coupled receptor 44
25 Hepatitis A virus cellular receptor 2
26 Inducible T-cell co-stimulator
27 Interferon, gamma
28 Immunoglobulin superfamily, member 6
29 Interleukin 10
30 Interleukin 12B
31 Interleukin 12 receptor, beta 2
32 Interleukin 13
33 Interleukin 13 receptor, alpha 1
34 Interleukin 15
35 Interleukin 18 (interferon-gamma-inducing factor)
36 Interleukin 18 receptor 1
37 Interleukin 1 receptor, type I
38 Interleukin 1 receptor, type II
39 Interleukin 2
40 Interleukin 2 receptor, alpha
41 Interleukin 4
42 Interleukin 4 receptor
43 Interleukin 5 (colony-stimulating factor, eosinophil)
44 Interleukin 6 (interferon, beta 2)
45 Interleukin 6 receptor
46 Interleukin 7
47 Interleukin 9
48 Inhibin, alpha
49 Inhibin, beta A (activin A, activin AB alpha polypeptide)
50 Interferon regulatory factor 1
51 Interferon regulatory factor 4
52 Janus kinase 1 (a protein tyrosine kinase)
53 Janus kinase 2 (a protein tyrosine kinase)
54 Lymphocyte-activation gene 3
55 Linker for activation of T cells
56 V-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)
57 Mitogen-activated protein kinase kinase 7
58 Mitogen-activated protein kinase 8
59 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1Virology Journal 2008, 5:165 http://www.virologyj.com/content/5/1/165
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genes among the different human cell types, these genes
include cytokine genes representative of Th1, Th2 and Th3
cells, transcriptional factors that regulate the expression of
these cytokines as well as other markers of CD4+ T lym-
phocytes. Genes involved in immune cell activation and
the Th1 and Th2 type immune responses were also noted.
From these, 20 genes were identified and these genes may
contribute to the immuno-regulation of DENV pathogen-
esis. This study provided a first insight to the differential
regulation of Th genes during DENV infection of different
human cell types.
Dengue virus is known to be able to infect different kinds
of cell types in human [7]. In this study, the susceptibility
of human cell lines, K562, Jurkat and HepG2 to DENV 2
virus infection was first determined. K562 is a myeloge-
nous cell line with monocyte and granulocyte properties
[8]. Jurkat is a T cell lymphoblast-like cell line [9] and
HepG2 is a heptocellular liver cell line [10]. Both K562
and Jurkat cells were selected for analysis as they are of
immune origin and the HepG2 cell line was selected since
dengue virus is hepatotrophic. The use of human cell lines
for this study has been given approval by the National
University of Singapore Institutional Review Board. These
human cell lines were first subjected to low passage
human isolate DENV (serotype 2, Singapore strain
Den2ST) infection at a multiplicity of infection of 10. At
different time points post-infection, virus containing
supernatant were harvested for plaque assays and the
DENV-infected cells were stained for immunofluores-
cence detection of viral antigen (envelope protein) pro-
duction via flow cytometry. All the three human cell lines
are shown to be highly susceptible to dengue virus infec-
tion, producing reasonably high virus titers by 3 days
post-infection (Figure 1a). Production of viral antigen was
also detected in all the three cell lines by 3 days post-infec-
tion (Figure 1b).
Next, all the three human cell lines were infected with
DENV2 and processed for RT-PCR array experiments.
Three independent DENV infection experiments were car-
ried out to ensure the reproducibility of the changes in
gene expression. Total RNA of the human cells (K562/Jur-
kat/HepG2) was extracted using the Qiagen RNeasy Kit.
The quality and integrity of the total RNA extracted from
mock-infected and dengue virus-infected cells on day 3
post-infection was first checked by running a portion of
the total RNA on 1% agarose gel to detect for human
ribosomal RNA, 28S and 18S. Human Th1-Th2-Th3 RT2
Profiler™ PCR Array (Superarray) was used for the simul-
taneous profiling of 84 genes related to the three classes of
helper T cells. RT2 First Strand Kit (Superarray) was used
for reverse transcription to obtain cDNA from total RNA.
Five housekeeping genes (β-2-microglobulin, hypoxan-
thine phosphoribosyltransferase 1, ribosomal protein
L13a, glyceraldehyde-3-phosphate dehydrogenase and β-
actin) were included in the array to minimize functional
biases.
Genes with fold value more than 2 in absolute value were
considered to be differentially regulated. P-value of 3
independent control experiments and test experiments
60 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
61 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein
62 Polycomb group ring finger 2
63 Protein tyrosine phosphatase, receptor type, C
64 Surfactant, pulmonary-associated protein D
65 Suppressor of cytokine signaling 1
66 Suppressor of cytokine signaling 2
67 Suppressor of cytokine signaling 5
68 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)
69 Signal transducer and activator of transcription 1, 91kDa
70 Signal transducer and activator of transcription 4
71 Signal transducer and activator of transcription 6, interleukin-4 induced
72 T-box 21
73 Transcription factor CP2
74 Transforming growth factor, beta 3
75 Toll-like receptor 4
76 Toll-like receptor 6
77 Transmembrane emp24 protein transport domain containing 1
78 Tumor necrosis factor (TNF superfamily, member 2)
79 CD27 molecule
80 Tumor necrosis factor receptor superfamily, member 8
81 Tumor necrosis factor receptor superfamily, member 9
82 Tumor necrosis factor (ligand) superfamily, member 4
83 Tyrosine kinase 2
84 YY1 transcription factor
Table 1: Complete list of genes tested in the Th genes RT-PCR array. (Continued)Virology Journal 2008, 5:165 http://www.virologyj.com/content/5/1/165
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obtained for each gene was calculated. The differential
regulation of the Th genes upon DENV infection of the
human cell types are tabulated in Tables 2, 3 and 4. The
Th genes are further classified based on their potential
pathogenesis-induced classes (immune cell activation,
inflammation, thrombocytopenia and vascular permea-
bility) with reference to the description of the gene func-
tion summarized from Online Mendelian Inheritance in
Man (OMIM), National Center for Biotechnology Infor-
mation, National Library of Medicine http://
www.ncbi.nlm.nih.gov/omim/ as of November 2008.
From these genes, a group of 20 genes that may provide
the molecular basis of the observed pathogenesis in the
human cells upon DENV infection was identified (Tables
2, 3 and 4 – bolded). The criterion for the selection of
these genes was based on their ability to enhance immune
cell activation, inflammatory responses, thrombocytope-
nia as well as vascular permeability upon differential reg-
ulation. The complete gene expression profiles of all the
three cell lines infected with DENV were provided (Figures
2, 3 and 4). The Th genes that were either up or down-reg-
ulated significantly in the different cell types were also
Infectivity of human cell lines with DENV Figure 1
Infectivity of human cell lines with DENV. (a) Growth curves of DENV in different human cell types. (b) Detection of 
DENV viral antigen (envelope protein) in different human cell types via flow cytometry analysis. All the human cells were 
shown to support DENV replication and high infectious virus titers were also obtained from the cells at 3 days post-infection.
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indicated in the volcano plots as shown in Figures 2, 3 and
4. RANTES, CC-CKR-3, TLR6 and IL-6 were highly up-reg-
ulated in Jurkat and K562 cells upon infection with den-
gue virus. CD40L was shown to be significantly down-
regulated in both Jurkat and HepG2 cells upon dengue
virus infection.
Dengue virus infection causes dengue fever (DF), dengue
hemorrhagic fever (DHF), and dengue shock syndrome
(DSS), whose pathogenesis are not clearly understood.
Current hypotheses of antibody-dependent enhance-
ment, virus virulence, and IFN-gamma/TNF α-mediated
immuno-pathogenesis are insufficient to explain clinical
manifestations of DHF/DSS such as thrombocytopenia
and hemoconcentration [11]. Furthermore, Chaturvedi
and co-workers (1999) documented a shift from a Th1
response in mild dengue to a Th2 response in severe den-
gue haemorrhagic fever [12]. Increased serum levels of IL-
4, IL-6 and IL-10 were observed mainly in cases of DHF
grades III and IV. In contrast, the levels of IFN-γ and IL-2
were highest in cases of DF and low in DHF grade IV.
Hence, these data indicated the importance of Th genes in
mediating the pathogenesis of DENV infection.
Table 2: Differentially regulated Th genes of Jurkat cells infected with DENV.
Gene Gene name Fold Change Immune cell 
activation
Inflammatory 
responses
Thrombo-cytopenia Vascular 
permeability
Th1 immune 
response
CSF2 GMCSF 2.08 4444
APT1LG1/
CD178
FASLG 2.18 4
INHA Inhibin, alpha 2.19 3
CLMF/CLMF2 Interleukin 12B 2.20 44
CD80 CD28LG/
CD28LG1
2.29 3
IFNG Interferon, 
gamma
2.85 444
IL18 Interleukin 18 3.69 44 4
IL2 Interleukin 2 3.97 4444
TLR6 Toll-like 
receptor 6
8.68 4444
CD182/CD183 CXCR3 -2.12 33
Th2 immune 
response
RANTES Chemokine 
ligand 5
2.11 4444
CC-CKR-2/
CCR2A
Chemokine 
receptor 2
2.95 444
CBP/RSTS CREB binding 
protein
3.00 4
CC-CKR-3/
CD193
Chemokine 
receptor 3
4.64 44
Th1\Th2 immune 
response
BSF2/HGF Interleukin 6 2.16 4444
CTLA4 Cytotoxic T-
lymphocyte-
associated 
protein 4
2.64 4
IRF4 Interferon 
regulatory factor 
4
9.27 44
CD154/CD40L CD40 ligand -2.13 3333
4-1BB/CD137 Tumor necrosis 
factor receptor 
superfamily
-3.49 44 4
Transcriptional 
Factors
SOCS2 Suppressor of 
cytokine 
signaling 2
2.09 44Virology Journal 2008, 5:165 http://www.virologyj.com/content/5/1/165
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Table 3: Differentially regulated Th genes of K562 cells infected with DENV.
Gene Gene name Fold Change Immune cell 
activation
Inflammatory 
responses
Thrombo-cytopenia Vascular 
permeability
Th1 immune 
response
RP11-102M16.1 Interleukin 12 
receptor
2.01 33
DIF/TNF-alpha Tumor necrosis 
factor α 
2.06 44
CC-CKR-5/
CCCKR5
Chemokine 
receptor 5
2.30 44
CSF2 GMCSF 2.45 4444
CD80 CD28LG/
CD28LG1
2.60 3
TLR6 Toll-like 
receptor 6
6.04 4444
CD69 CLEC2C 14.62 4444
IL2 Interleukin 2 -2.20 4444
APT1LG1/CD178 FASLG -2.48 3
CLMF/CLMF2 Interleukin 12B -3.35 33
CD121b/IL1RB Interleukin 1 
receptor
-3.67 3
Th2 immune 
response
CC-CKR-2/
CCR2A
Chemokine 
receptor 2
2.14 444
CC-CKR-4/CKR4 Chemokine 
receptor 4
3.25 4444
CC-CKR-3/
CD193
Chemokine 
receptor 3
4.44 44
RANTES Chemokine 
ligand 5
31.78 4444
BSF1/IL-4 Interleukin 4 -2.25 4444
HDR GATA binding 
protein 3
-2.61 33
IL1RL1LG/Il1rl1l Transmembrane 
emp24 protein 
transport domain
-2.74 3
AILIM/CD278 Inducible T-cell co-
stimulator
-2.75 3
CD124/IL4RA Interleukin 4 
receptor
-3.52 33
FIC/MARC Chemokine ligand 7 -3.76 33 3
Th1\Th2 immune 
response
LAT Linker for 
activation of T cells
4.69 3
4-1BB/CD137 Tumor necrosis 
factor receptor 
superfamily
4.98 44 4
BSF2/HGF Interleukin 6 6.96 4444
IL-7 Interleukin 7 -2.87 333
PTPRC Protein tyrosine 
phosphatase, 
receptor type, C
-3.39 333
Transcriptional 
Factors
SOCS2 Suppressor of 
cytokine 
signaling 2
2.27 44
ZNF163 Growth factor 
independent 1
-2.01 33Virology Journal 2008, 5:165 http://www.virologyj.com/content/5/1/165
Page 7 of 11
(page number not for citation purposes)
In this study, we have been able to identify 20 Th and Th-
related genes from the RT-PCR arrays that may contribute
to the molecular basis of DENV pathogenesis. The 20
genes were selected based on their differential regulation
and their implications in mediating immune cell activa-
tion, inflammatory responses, thrombocytopenia and
vascular permeability during DENV infection. Neverthe-
less, the involvement of these genes on the molecular
pathogenesis of DENV infection warrant further cohort
studies on patients with DENV infection and these studies
are currently being conducted in our laboratory.
Jurkat and K562 cells being immune cells have more dif-
ferentially regulated Th related genes upon DENV infec-
tion when compared with HepG2 hepatocytes (Tables 2,
3 and 4). Fas ligand, IL-2 and IFN-γ up-regulation in Jur-
kat cells were also reported in studies using DENV-
infected T cell clones [13]. Up-regulation of RANTES and
IL-6 in dengue 2 virus-infected K562 cells was also
reported by King and co-workers, showing elevated
RANTES and IL-6 in DENV-infected mast cells and mono-
cytes [14]. An earlier study by Liu and co-worker reported
the expression of CD69 on monocytes at day 4 after the
onset of fever which also substantiated the observation of
CD69 up-regulation in DENV-infected K562 cells in this
study [15]. Hence, the consistency of the data obtained
from this study with previous published studies provided
this experimental approach with confidence.
The observation of the few similar Th related gene regula-
tion between the three cell lines suggested that the DENV
triggered Th gene expression that was cell-type dependent
in the RT-PCR array. Another gene profiling study per-
formed on DENV-infected cells also observed cell-type spe-
cific gene changes [6]. Nevertheless, a group of Th1 and Th2
genes inducing cell activation and inflammation (GMCSF,
RANTES, TLR6 and CC-CKR-3) were found to be signifi-
cantly up-regulated in both K562 and Jurkat cells, this may
imply the presence of potential cross-talking pathways that
mediate common inflammatory responses during DENV
infection. More studies are now being conducted to further
verify this interesting observation. The over-expression or
inappropriate inflammation can lead to tissue destruction
commonly observed in DSS/DHF [16].
Table 4: Differentially regulated Th genes of HepG2 hepatocytes infected with DENV.
Gene Gene name Fold Change Immune cell 
activation
Inflammatory 
responses
Thrombo-cytopenia Vascular 
permeability
Th1 immune 
response
S152/T14 CD 27 -2.06 3
CSF2 GMCSF -2.91 3333
CDw218a/IL-1Rrp Interleukin 18 
receptor 1
-3.15
Tp44 CD28 -7.07 3
CD154/CD40L CD40 ligand -9.20 3333
Th2 immune 
response
AILIM/CD278 Inducible T-cell co-
stimulator
2.28 3
CC-CKR-2/
CCR2A
Chemokine 
receptor 2
4.08 444
CC-CKR-3/
CD193
Chemokine 
receptor 3
4.54 44
HP40/IL-9 Interleukin 9 -2.49 33 3
BSF1/IL-4 Interleukin 4 -2.73 3333
EDF/IL-5 Interleukin 5 -7.12 33
Th1\Th2 immune 
response
PTPRC Protein tyrosine 
phosphatase, 
receptor type, C
-3.73 333
4-1BB/CD137 Tumor necrosis 
factor receptor 
superfamily
-3.41 33 3
Transcriptional 
Factors
STAT4 Signal transducer 
and activator of 
transcription 4
-2.17 33Virology Journal 2008, 5:165 http://www.virologyj.com/content/5/1/165
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Expression and statistical validation profiles of Th genes in dengue virus infected Jurkat cells Figure 2
Expression and statistical validation profiles of Th genes in dengue virus infected Jurkat cells. The differential reg-
ulation (up or down-regulated) of the 84 Th and Th-related genes upon dengue virus infection of Jurkat cells are shown. Genes 
with greater than 3Log2 fold increase are indicated in the respective graphs of each cell types. The volcano plot of the RT-PCR 
array for each of the cell types is also provided. The plot arranges Th genes along dimensions of differential regulation (either 
up or down-regulation – X axis) and statistical significance (Y-axis). The higher values on the Y-axis indicate statistical signifi-
cant of the up or down-regulated genes.
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Expression and statistical validation profiles of Th genes in dengue virus infected K562 cells Figure 3
Expression and statistical validation profiles of Th genes in dengue virus infected K562 cells. The differential regu-
lation (up or down-regulated) of the 84 Th and Th-related genes upon dengue virus infection of K562 cells are shown. Genes 
with greater than 3 Log2fold increase are indicated in the respective graphs of each cell types. The volcano plot of the RT-PCR 
array for each of the cell types is also provided. The plot arranges Th genes along dimensions of differential regulation (either 
up or down-regulation – X axis) and statistical significance (Y-axis). The higher values on the Y-axis indicate statistical signifi-
cant of the up or down-regulated genes.
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Expression and statistical validation profiles of Th genes in dengue virus infected Hep G2 cells Figure 4
Expression and statistical validation profiles of Th genes in dengue virus infected Hep G2 cells. The differential 
regulation (up or down-regulated) of the 84 Th and Th-related genes upon dengue virus infection of HepG2 cells are shown. 
Genes with greater than 3 Log2fold increase are indicated in the respective graphs of each cell types. The volcano plot of the 
RT-PCR array for each of the cell types is also provided. The plot arranges Th genes along dimensions of differential regulation 
(either up or down-regulation – X axis) and statistical significance (Y-axis). The higher values on the Y-axis indicate statistical 
significant of the up or down-regulated genes.
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For dengue virus infection, the severity of the disease is
best indicated by the extent of plasma leakage. A major
group of genes (GMCSF, RANTES, IL2, INFγ, TLR6,
CCR2A, IL-6, CKR-4) causing thrombocytopenia and vas-
cular permeability was also found to be up-regulated in all
three cell types. These gene products are known mediators
of thrombocytopenia and vascular permeability. In con-
sistent with previous studies, some of these genes have
also been reported to be up-regulated during dengue
infection, including RANTES [17] and IL-6 [18]. In addi-
tion, the down-regulation of IL-4 was observed in K562
cells and this has important implication in causing vascu-
lar permeability [19]. The over-expression of these cellular
Th genes might play a crucial role in enhanced production
of anti-platelet or anti-endothelial cell autoantibodies,
elevated levels of tPA, as well as a deficiency in coagula-
tion. Therefore, damaged endothelial cells may upset the
procoagulant/anticoagulant balance of endothelium and
increase the tendency of bleeding. Activated endothelial
cells may also contribute to the development of thrombo-
cytopenia by sequestering platelets [20].
In summary, the focused Th genes RT-PCR array profiling
showed a complex network of DENV-induced cell interac-
tions during infection. The array-based Th gene profiles
documented in this study may also serve as potential
biomarkers for DENV infection. Nevertheless, further ver-
ification of these differentially regulated Th genes on
DENV-infected patient samples will be helpful. Compara-
tive profiling of Th genes in different human cell types in
response to DENV infection may therefore provide inter-
esting insights into the possible molecular mechanisms
behind the observed cyto-pathology in DENV infection.
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